These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8198749)

  • 1. The immunogenicity of glycerol-preserved donor skin.
    Hettich R; Ghofrani A; Hafemann B
    Burns; 1994; 20 Suppl 1():S71-5; discussion S75-6. PubMed ID: 8198749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of maintaining an in-house glycerol-preserved skin bank.
    Yeo SY; Hamzan MI; Wan Sulaiman WA; Halim AS
    Burns; 2022 Mar; 48(2):390-395. PubMed ID: 34670715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cologne Burn Centre experience with glycerol-preserved allogeneic skin: Part II: Combination with autologous cultured keratinocytes.
    Stark GB; Kaiser HW
    Burns; 1994; 20 Suppl 1():S34-8. PubMed ID: 8198740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cologne Burn Centre experiences with glycerol-preserved allogeneic skin: Part I: Clinical experiences and histological findings (overgraft and sandwich technique).
    Horch R; Stark GB; Kopp J; Spilker G
    Burns; 1994; 20 Suppl 1():S23-6. PubMed ID: 8198737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History of the Euro Skin Bank: the innovation of preservation technologies.
    Hoekstra MJ; Kreis RW; du Pont JS
    Burns; 1994; 20 Suppl 1():S43-7. PubMed ID: 8198743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Banking and use of glycerol preserved full-thickness skin allograft harvested from body contouring procedures.
    Zidan SM; Eleowa SA
    Burns; 2014 Jun; 40(4):641-7. PubMed ID: 24070848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indication for and results of the application of glycerol-preserved homologous split-thickness skin following burns].
    Bruck JC; Büttemeyer R; Grabosch A; Weyer A
    Beitr Orthop Traumatol; 1990 Sep; 37(9):504-6. PubMed ID: 2248607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with glycerol-preserved donor skin treatment in partial thickness burns.
    Hermans MH
    Burns Incl Therm Inj; 1989 Feb; 15(1):57-9. PubMed ID: 2655834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of human amnion preserved long-term in glycerol as a temporary biological dressing.
    Maral T; Borman H; Arslan H; Demirhan B; Akinbingol G; Haberal M
    Burns; 1999 Nov; 25(7):625-35. PubMed ID: 10563689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observations on stability and contraction of composite skin grafts: xenodermis or allodermis with an isograft overlay.
    Fang CH; Robb EC; Yu GS; Alexander JW; Warden GD
    J Burn Care Rehabil; 1990; 11(6):538-42. PubMed ID: 2286608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of glycerolized human allografts as temporary (and permanent) cover in adults and children.
    Hussmann J; Russell RC; Kucan JO; Hebebrand D; Bradley T; Steinau HU
    Burns; 1994; 20 Suppl 1():S61-5; discussion S65-6. PubMed ID: 8198747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of indirect donor-specific hyporesponsiveness by transportal RT1-peptide pulse in rat skin transplantation.
    Yamamura M; Yagi T; Iwagaki H; Mitsuoka N; Jie L; Sheng SD; Matsuda H; Sadamori H; Inagaki M; Tanaka N
    Transpl Int; 2003 Aug; 16(8):451-5. PubMed ID: 12719799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
    Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance induction in composite facial allograft transplantation in the rat model.
    Demir Y; Ozmen S; Klimczak A; Mukherjee AL; Siemionow M
    Plast Reconstr Surg; 2004 Dec; 114(7):1790-801. PubMed ID: 15577350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-specific immune response after aortic valve allografting in the rat.
    Zhao XM; Green M; Frazer IH; Hogan P; O'Brien MF
    Ann Thorac Surg; 1994 May; 57(5):1158-63. PubMed ID: 8179379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.
    Nakafusa Y; Goss JA; Mohanakumar T; Flye MW
    Transplantation; 1993 Apr; 55(4):877-82. PubMed ID: 8475563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of recipient pretreatment with donor spleen cells and 15-deoxyspergualin on rat skin graft survival.
    Krzymański M; Oko A; Waaga AM; Pawliczak E; Wiktorowicz K
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):459-63. PubMed ID: 9437503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of perioperative administration of donor lymphocytes via portal vein in rat skin transplant model].
    Lee CJ; Yoshimura N; Hamashima T; Osaka Y; Oka T
    Nihon Geka Gakkai Zasshi; 1991 May; 92(5):489-95. PubMed ID: 1831532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstruction of human skin from glycerol-preserved allodermis and cultured keratinocyte sheets.
    McKay I; Woodward B; Wood K; Navsaria HA; Hoekstra H; Green C
    Burns; 1994; 20 Suppl 1():S19-22. PubMed ID: 8198736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide-induced tolerance in rat orthotopic liver transplantation.
    Okano S; Eto M; Tomita Y; Yoshizumi T; Yamada H; Minagawa R; Nomoto K; Sugimachi K; Nomoto K
    Transplantation; 2001 Feb; 71(3):447-56. PubMed ID: 11233909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.